Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?
AUTOR(ES)
Croft, Ashley M
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=101408Documentos Relacionados
- Mefloquine: contraindicated in patients with mood, psychotic or seizure disorders
- Food, drug, and cosmetic dyes: biological effects related to lipid solubility.
- The antimalarial drug mefloquine binds to membrane phospholipids.
- The effects of the "vestibular sedative" drug, Flunarizine upon the vestibular and oculomotor systems.
- Collaborative Involvement of Primary and Secondary Caregivers: Associations with Youths' Diabetes Outcomes